NCAA investigates unprecedented rise in academic fraud cases
The more than 20 open cases represent an “epidemic,” according to NCAA Vice President of Enforcement Jonathan Duncan.
Bloomberg News
Articles
FDA mistakenly blamed Lilly for making Cialis-Viagra combo
The Food and Drug Administration acknowledged the mistake Friday in an e-mail and said it removed Indianapolis-based Lilly’s name from an import alert that attributed the pills to the company’s office in Australia.
NCAA revenue rises for 14th straight year as changes loom
The growth comes as the Indianapolis-based NCAA prepares major governance changes aimed at providing more money to athletes, and continues to fight lawsuits and public pressure that challenge its structure.
Holiday sales rise 4 percent despite December dropoff
U.S. holiday sales marked their biggest increase since 2011, even amid evidence of a consumer-spending slowdown in December, according to the National Retail Federation.
Lilly sees insurers pushing harder for discounts
Health-coverage managers are becoming more aggressive in demanding discounts and exclusive deals from drugmakers to drive down the cost of medicine, Eli Lilly and Co.’s diabetes business chief says.
United says 2,000 airport jobs may be outsourced to cut costs
Outside contractors may take over the positions at 28 airports, including those serving Indianapolis, Atlanta and St. Louis, a United spokesman said.
UPDATE: Lilly says it couldn’t have made tainted Cialis
A batch of Cialis pills, purportedly made at a plant in Australia, was banned by the FDA from entering the U.S. after the pills were found to contain the active ingredient for rival drug Viagra. Cialis manufacturer Eli Lilly said it doesn’t make any drugs in Australia.
Indiana fertilizer plant not seeking state incentives
A Pakistani-backed company planning to build a $2.6 billion fertilizer plant in southwestern Indiana announced Thursday it has withdrawn its request for state economic incentives.
College Playoff, NCAA to offset travel costs for athlete parents
Players in football and basketball championships will get help with family travel expenses for the first time under new policies by the College Football Playoff and the NCAA.
Companies explore options for counterattacks on hackers
A growing number of firms are considering ways to break into hackers’ networks to retrieve stolen data or even knock their computers offline. Such actions could push the limits of existing law.
Zimmer to pay Stryker $70M in surgical device fight
The award is actually less than a third of what Warsaw-based Zimmer was originally ordered to pay for infringing patents on a lavage device.
Law school enrollment plummets to 27-year low, ABA says
Total law school enrollment at the 204 accredited schools is 119,775, a 6.9-percent decrease from last year and an 18-percent decrease from its record high in 2010.
Oliver Luck leaving West Virginia for position at NCAA
West Virginia University Athletic Director Oliver Luck, the father of Colts QB Andrew Luck, is joining the Indianapolis-based NCAA as executive vice president of regulatory affairs.
Apple defeats $1 billion iPod antitrust suit in three hours
Apple Inc. quickly dispensed with a $1 billion lawsuit by iPod users claiming software updates for the device were meant to block competitors, as a jury ruled for the company after only three hours of deliberations.
Terrorists remain fixated on airlines, departing TSA chief says
John Pistole, outgoing head of the Transportation Security Administration and soon-to-be president of Anderson University, said the greatest threat to national security is still someone slipping a bomb onto a plane bound for the United States.
Alzheimer’s tests present dilemma of knowing the future
While the tests will likely help drug companies like Eli Lilly and Co. evaluate medicines, they’ll also create wrenching personal and ethical dilemmas for patients who will have to live with the knowledge that they’re destined to develop the disease.
Covance shareholder sues over $6.1B LabCorp deal
A Covance Inc. investor contends in a lawsuit that the drug-testing company’s board erred in relying on what the shareholder called Goldman Sachs Group Inc.’s conflict-tainted advice. Covance has major laboratory operations in Indianapolis.
Lilly rheumatoid arthritis drug meets goals in final-stage trial
If approved, Baricitinib may bring Lilly $673 million in 2020, according to the average of five analysts’ estimates compiled by Bloomberg.
Avanir’s Takeover Price Leaves Room for Counteroffers
Avanir Pharmaceuticals Inc. has reached a The Aliso Viejo, California-based company, which makes a drug to control symptoms of Alzheimer’s disease, this week agreed to sell itself to Japan’s Otsuka Holdings Co. for $3.2 billion, or $17 a share. That’s 4 percent lower than analysts’ average projection for where the stock would have traded in […]
Lilly competitor claims early success with Alzheimer’s drug
Biogen Idec Inc. shares rose Tuesday after the company said its Alzheimer’s drug showed promising early results and will be quickly moved into a final-stage trial.